L3Harris Marks Major Milestone for New Solid Rocket Motor ‘Factories of the Future' in Virginia
CULPEPER, Va.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) has broken ground on the construction of five new solid rocket motor facilities in Virginia that will boost production to support key national defense programs. The new facilities will incorporate modular factory design, robotic flex cells, automated, progressive casting and improved handling and assembly throughout the production line.
'L3Harris' growth in Virginia is another solid example of how we're expanding our rocket motor manufacturing infrastructure to support the nation's defense propulsion needs,' said Ken Bedingfield, President, Aerojet Rocketdyne, L3Harris. 'Made possible through a Defense Production Act Title III cooperative agreement, this expansion will complement an existing 256,000 square feet of manufacturing space, supporting some of the most advanced propulsion research and production in the world.'
L3Harris' site in Virginia hosts the company's Center of Excellence for Propellant Research and Small to Medium-sized Solid Rocket Motor Production. The expansion includes a 12,000 square foot, state-of-the-art solid rocket motor cast and assembly facility, as well as a control room, facilities to support mixing and grinding operations and upgrades to the site's motor testing capabilities. The consolidated cast and assembly building will centralize production of a critical program under one roof, reducing the distance motors travel during manufacturing by 90%.
'L3Harris' continued expansion in Virginia underscores the Commonwealth's pivotal role in safeguarding our nation's security,' said Virginia Gov. Glenn Youngkin. 'With a world-class workforce, cutting-edge infrastructure, and a strategic East Coast location, Virginia offers the ideal environment for defense and aerospace leaders like L3Harris to grow and drive innovation for the future.'
'I'm proud of Virginia's continued leadership in the defense sector, which is made possible in part through crucial investments like L3Harris' new solid rocket motor facilities,' said Sen. Tim Kaine, D-Va. 'I'll keep looking for opportunities to support Virginia's robust defense industry—a core pillar of Virginia's economy and a key component of our military readiness.'
'Thrilled to see L3Harris expand its presence in Virginia and continue to strengthen our defense industrial base,' said Sen. Mark R. Warner, D-Va. 'This investment in Orange County will support the world-class research and manufacturing coming out of Virginia, while also creating valuable jobs for American workers.'
'This investment by L3Harris underscores how the Seventh Congressional District, and Virginia overall, remains a great place to build systems critical to our national security. This project will yield exactly the kind of smart, strategic growth we need in the Seventh District to strengthen our national security, rebuild America's defense industrial base, and build key components for munitions such as the Javelin,' said Rep. Eugene Vindman, D-Va. 'As an Army veteran and a member of the House Armed Services Committee, I will prioritize supporting projects that ensure our service members have the tools they need to keep our country safe — while creating more good jobs right here in the Seventh.'
'Investment in key capabilities for domestic defense production is integral to our efforts to continue to support warfighter requirements,' said Greg Davis, Acting Director, Manufacturing Capability Expansion and Investment Prioritization, Office of the Assistant Secretary of Defense for Industrial Base Policy. 'It's also an important component to the Department's priority of revitalizing the defense industrial base.'
L3Harris is also modernizing and expanding its solid rocket motor production in two other states. The company is constructing new solid rocket motor facilities in Camden, Arkansas, and is transitioning production of inert components for critical missile systems to align with the sites' core competencies in Huntsville, Alabama. The company is already ramping up production due to digital process improvements as well as new tooling and equipment.
About L3Harris Technologies
L3Harris Technologies is the Trusted Disruptor in the defense industry. With customers' mission-critical needs always in mind, our employees deliver end-to-end technology solutions connecting the space, air, land, sea and cyber domains in the interest of national security. Visit L3Harris.com for more information.
Forward-Looking Statements
This press release contains forward-looking statements that reflect management's current expectations, assumptions and estimates of future performance and economic conditions. Such statements are made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The company cautions investors that any forward-looking statements are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements. Statements about future capacity are forward-looking and involve risks and uncertainties. L3Harris disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
CAL Q1 Earnings Call: Management Cites Tariff and Sourcing Headwinds, Suspends Guidance
Footwear company Caleres (NYSE:CAL) missed Wall Street's revenue expectations in Q1 CY2025, with sales falling 6.8% year on year to $614.2 million. Its non-GAAP EPS of $0.22 per share was 39.7% below analysts' consensus estimates. Is now the time to buy CAL? Find out in our full research report (it's free). Revenue: $614.2 million (6.8% year-on-year decline) Adjusted EPS: $0.22 vs analyst expectations of $0.37 (39.7% miss) Adjusted Operating Income: $12.21 million vs analyst estimates of $19.4 million (2% margin, 37.1% miss) Operating Margin: 1.9%, down from 6.6% in the same quarter last year Market Capitalization: $558.4 million Caleres' first quarter results were shaped by softer consumer demand and operational pressures across both its Brand Portfolio and Famous Footwear segments. CEO Jay Schmidt pointed to particularly weak February sales, with some improvement in March and April, though overall performance remained below plan. Management attributed the underperformance to lower gross margins, higher inventory reserves, and increased costs tied to sourcing disruptions and tariffs. Schmidt acknowledged, 'Our first quarter results fell short of expectations,' highlighting the company's exposure to both macroeconomic volatility and specific industry challenges. Additional factors included higher-than-anticipated bad debt write-downs, as customer credit conditions worsened compared to last year. Looking ahead, Caleres is suspending formal guidance due to ongoing volatility in tariffs and global sourcing. Management emphasized a focus on cost controls and structural expense reductions, with CFO Jack Calandra detailing a $15 million annualized SG&A reduction initiative. The company is also navigating uncertainty around tariff timelines and potential sourcing disruptions, which could impact both gross margins and inventory. Schmidt noted, 'We must redouble our efforts to drive growth and profitability,' while also pointing to upcoming product launches and store format changes, such as the broader rollout of the Jordan brand and continued expansion of FLAIR locations, as key initiatives to support future performance. The planned integration of Stuart Weitzman is expected to further diversify the portfolio. Management cited tariff escalation, sourcing disruption, and inventory management as the primary drivers behind the quarter's margin and earnings pressure, while highlighting selective strength in international and direct-to-consumer channels. Tariff and sourcing disruption: The company experienced increased costs and operational complexity from shifting production out of China following new U.S. tariffs. This led to order cancellations, higher costs to relocate manufacturing, and additional inventory write-downs, which collectively pressured gross margins. Inventory management challenges: Caleres was unable to adjust its inventory flow quickly enough as demand softened, resulting in elevated inventory levels and a need for higher markdown reserves, especially in its Brand Portfolio segment. International segment growth: Despite overall declines, international sales—particularly from the Sam Edelman brand—showed double-digit growth, supported by expansion in China, the Middle East, and new marketplace partnerships. Management views these international gains as a strategic counterbalance to domestic softness. Brand Portfolio performance: Lead brands such as Sam Edelman outperformed others, with new product assortments like sneakers and sandals resonating well in key markets. However, Allen Edmonds and Naturalizer faced distinct category challenges, and Vionic's decline was attributed to a timing shift in catalog drops. Famous Footwear and product initiatives: The Famous Footwear segment experienced sequential sales improvement during the quarter, aided by growth in e-commerce and the launch of new brands and store formats. The introduction of the Jordan brand and continued rollout of FLAIR stores are anticipated to boost performance in upcoming periods. Caleres' outlook is shaped by volatile tariff policies, cost-saving initiatives, and evolving consumer demand across its core segments. Tariff environment remains fluid: Management has suspended forward guidance due to ongoing uncertainty around U.S. tariffs on Chinese and global imports. Sourcing disruption and possible further escalation or reversal of tariffs could materially affect gross margins and inventory costs in the next several quarters. Expense reduction and operational efficiency: The company is implementing a $15 million annualized SG&A reduction, with savings expected to materialize in the second half of the year. This initiative is designed to offset profit pressure from lower sales and higher sourcing costs, though management noted that further opportunities for efficiency may emerge as integration partners assess the business. Product and format innovation: Upcoming launches, such as the full-door rollout of the Jordan brand at Famous Footwear and expanded FLAIR store locations, are expected to drive renewed customer engagement. Management also cited ongoing investment in international markets and the integration of Stuart Weitzman as potential growth levers, even as domestic wholesale order books remain 'fluid.' Over the coming quarters, the StockStory team will track (1) the company's ability to reduce inventory and capture anticipated SG&A savings, (2) the impact of new product launches—particularly the Jordan brand rollout and FLAIR store conversions—on segment sales, and (3) progress on the integration and performance of Stuart Weitzman. The evolution of global tariff policy and sourcing costs will also be critical to monitor. Caleres currently trades at a forward P/E ratio of 4.4×. Should you double down or take your chips? See for yourself in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today. Sign in to access your portfolio
Fox News
8 minutes ago
- Fox News
I'm a physician and I'm worried that our health agencies are facing increasing chaos
The American health system is bleeding out, and it desperately needs a real doctor. Leading Health and Human Services (HHS) today is like navigating a chaotic hospital — patients in every hallway, monitors screaming, seconds ticking away. Yet, instead of a seasoned physician who triages and trusts proven protocols, that hospital is overseen by an activist named Robert F. Kennedy Jr. A patient's oxygen level plummets; nurses turn to HHS Secretary Kennedy. Instead of orders, they get a lecture on conspiracies. Chaos follows. That chaos is now national. Our health agencies are trying to perform open-heart surgery while debating the effectiveness of a scalpel. Scientists who should be developing next-generation cancer vaccines are, instead, defending 60-year-old elementary science. Conspiracy ideology is beginning to take over, and we're all going to pay the price. I'm a board-certified physician and one of the most-followed online, and since Kennedy took office, I've been forced to swap from fact-checking Instagram influencers to fact-checking the nation's top public-health official. Our nation's health system is in shambles, and the leadership of HHS plays a pivotal role in fixing this disaster. That's why it's deeply alarming that Kennedy, who continues to spread misinformation and denies the fundamentals of medicine, remains at the helm of the agency. Although he claims he's "not anti-vaccine," his words and actions tell a different story. He recklessly attacks vaccine efficacy, spreads disproven theories linking vaccines to autism, and denies fundamental virology — from diseases like HIV, measles, and more. I'm all for healthy skepticism, but scientific skepticism means investigating data, not cherry-picking it … or making it up. These aren't privately held beliefs either — a post on his active X account states that the HPV vaccine "increases cervical-cancer risk" all despite mountains of real-world data showing up to 88% drops in cancer among vaccinated teens. Sweden, England, and even the CDC surveillance report plunging pre-cancer rates. Recently, he claimed, "50% of the population is diabetic" and that "one out of every three kids" already has the disease. In reality, true estimates put China's diabetes prevalence around 12%, and the U.S. pediatric figure closer to one in 300. If one of my interns inflated numbers by a factor of 10, they'd be sent back to remedial math. Kennedy does it regularly on primetime television. Worse, he's now canceled $12 billion in disease outbreak prevention programs, proposed a 26% cut to the NIH budget, and pink-slipped roughly 20,000 public-health scientists and staff. Those decisions have consequences: dozens of federally funded vaccine clinics in Arizona, Minnesota, Nevada, Texas and Washington were canceled just as measles cases blew past 1,000 — the worst surge in a generation. He's dismantling the firehouse while buildings are burning. Public health cannot survive an HHS head who guts the programs that keep us safe and then fans the very myths that make outbreaks explode. Kennedy's long record of undermining proven public health measures and spreading scientific falsehoods makes him a threat to millions of Americans. Certainly, he should never have been confirmed to lead the office in the first place, but choosing to leave him in charge is like handing the keys to a driver who continues to insist that stop signs and red lights are optional. Today, I say that Kennedy is the wrong person to lead HHS. The integrity of our nation's health agencies demands leadership grounded in facts, research, and transparency — not misinformation. Doctors like me take an oath to 'do no harm.' We must call out leaders like Secretary Kennedy when they cause great harm to public health. We must stop the bleeding.
E&E News
11 minutes ago
- E&E News
US Steel-Nippon deal raises emissions concerns
An emerging White House-backed deal to allow a Japanese firm to purchase U.S. Steel could have implications for the industry's greenhouse gas emissions. President Donald Trump plans to hold a rally Friday in Pittsburgh to celebrate the deal, which he has described as a 'planned partnership' with Nippon Steel that will be 'controlled by the United States.' But clean energy advocates are concerned that Nippon's acquisition of Pittsburgh-based U.S. Steel, one of the biggest American steel producers, could delay the industry's transition away from coal-based blast furnaces. Advertisement 'This deal poses real threats to steel decarbonization in the U.S.,' Astrid Grigsby-Schulte, project manager of the Global Iron and Steel Tracker at the firm Global Energy Monitor, said in an email. 'On a global scale, Nippon has a lot of work to do to align with net zero goals and this extends to their acquisition of U.S. steel.'
